Technology Offers Site map description
N
Universidad de Alcalá-OTRI posted this:
New technology for Air Traffic Management.A research group from a Spaniard university has designed a new system based on optimal control technology for Air Traffic Management (ATM). The new approach is mainly characterized by its adaptability capacity in situations where there are more than two aircrafts. Potential collaborations with international/national research centres and companies interested in applying the technology are sought.Universidad de Alcalá-OTRI posted this:
New technology for generating 4D-trajectories in aircrafts using dynamics and location information.A research group from a Spanish University has designed and implemented a new system based on a technology able to perform optimal navigation planning in aircrafts. The new approach is mainly characterized by its autonomously learning capacity and adaptability to changes in the dynamics of the platform and environment. Potential collaborations with international/national research centres and companies interested in applying the technology are sought.UNIVERSIDAD DE BURGOS posted this:
New test for components subjected to high pressure (up to 6000 bar)Test for components subjected to high pressure (pipes and driving elements) (up to 6000 bar) which allows: 1. To assess structural integrity and failure analysis. 2. To reproduce the work cycle (0-6000bar-0). 3. To know the performance of new components subjected to high pressure. 4. To determine the fatigue of the real component under the working pressure. 5. To perform hydraulic fracture and fatigue tests up to 6 000 bars.UNIVERSIDAD DE BURGOS posted this:
New test for components subjected to high pressure (up to 6000 bar)Test for components subjected to high pressure (pipes and driving elements) (up to 6000 bar) which allows: 1. To assess structural integrity and failure analysis. 2. To reproduce the work cycle (0-6000bar-0). 3. To know the performance of new components subjected to high pressure. 4. To determine the fatigue of the real component under the working pressure. 5. To perform hydraulic fracture and fatigue tests up to 6 000 bars.Universidad de Alcalá-OTRI posted this:
New therapeutic agents for the treatment of inflammatory disordersThe research group, « Heterobetaines », from Alcalá University in colaboration with the research group « Hipersensibility to medicines and inmmunitary innate response » form IDI La Paz, present a new generation of inhibitors of alfa tumoral necrosis factor (TNF-α) production, useful to prevent and / or treat inflamatory diseases. The group is looking for technical cooperation or license agreements with pharmaceutical companies, research centers or diagnostic and treatment against inflammatory diseases research institutions.Universitat de Lleida posted this:
New therapeutic candidate for Spinal Muscular AtrophyDevelopment of a therapeutic solution for Spinal Muscular Atrophy (SMA) focused to restore protein SMN levels in neurodegenerative disorder which primarily affecting motor neurons (MNs). Spinal Muscular Atrophy (SMA) is a genetic neuromuscular disease characterized by muscle atrophy and weakness. The disease generally manifests early in life and is the leading genetic cause of death in infants and toddlers. SMA is caused by defects in the Survival Motor Neuron 1 (SMN1) gene that encodes the SMN protein. The SMN protein is critical to the health and survival of the nerve cells in the spinal cord responsible for muscle contraction (motor neurons).CSIC - Consejo Superior de Investigaciones Científicas posted this:
New therapeutic cannabidiol derivativesNew therapeutic cannabidiol derivatives CSIC, Temple University, and the University of North Carolina Greensboro have developed pyrazolylbenzene-1,3-diols for diseases associated with G protein-coupled receptor 18 (GPR18) and in combination with transient receptor potential vanilloid 1 (TRPV1) potentially useful against a wide range of disorders. Industrial partners from the biotech or pharmaceutical industry are being sought to collaborate through joint development and patent license agreement. An offer for Patent LicensingOTRI-Universidad de Málaga posted this:
NEW THERAPEUTIC TARGET IN THE TREATMENT OF ALZHEIMERA study carried out through the use of systems biology, with the analysis of complex data, starting with omics data and using integrative tools for the analysis of dynamic and modular responses, has identified a candidate target and the use of its inhibitor as new useful drug to combat Alzheimer's disease. The present invention refers to the total or partial inhibition of the expression of the localized gene, or of the activity of the enzyme encoded by said gene, to be used for the treatment of Alzheimer's disease.
Technology Transfer Office (TTO) at Universidad de Málaga
Universidade de Santiago de CompostelaUniversidade de Santiago de CompostelaUniversidade de Santiago de CompostelaTechnology Transfer Office
Universidade de Santiago de Compostela posted this:
New Thermal Sensing for Microcalorimetry and Microfluidics (ERC-PoC project)The prototype developed within ERC-PoC "ANTS" project, has demonstrated its sensitivity for a new concept of microcalorimeters, as well as providing advantages in microfluidics. We aim to: a) Integrate this technology within microfluidic devices or applications where size and fast response time are crucial. b) Develop a High-Throughput Calorimetry going beyond the current capabilities on ITC. > Sensing element. Ferromagnetic permalloy line 4x28 µm x 20 nm thick: affordable, miniaturization… Sensor was fabricated in a single deposition. > Temporal response. Milliseconds, to stimulus >10 microwatts; further improvements are in progress. > Easy adoption. Compatible with standard configuration of microcalorimeters. > IPR: EP, US, CN, KR, JP
CNIC (TTO)Spanish National Center for Cardiovascular Research (CNIC)CNIC (TTO)Technology Transfer Office at Spanish National Center for Cardiovascular Research (CNIC)
View ProfileCNIC (TTO) posted this:
New tools to improve the diagnosis and treatment of early atherosclerosisCardiovascular diseases (CVDs) are the leading cause of death worldwide, with atherosclerosis (AT) being its main determinant. Currently, AT prevention is based on traditional scores that, however, fail to identify individuals at risk at early stages. The exact prevalence of subclinical atherosclerosis is impossible to determine, although it has been estimated in the USA that 50% of men and 64% of women who died of sudden cardiac death did not have a previous manifestation of the disease and most of them were not considered high risk according to the Framingham score. Subjects that suffer from CV events despite pharmacotherapy or those that are intolerant to it, emphasize the need for alternative treatments to be explored. CNIC researchers have discovered a metabolite as biomarker to identify individuals at risk at early stages, and the use of antagonist to this metabolite as new tool to improve the treatment of early AT. This treatment will be effective not only for AT, but also for autoinflammatory diseases.
Technology Transfer Office at Spanish National Center for Cardiovascular Research (CNIC)CSIC - Consejo Superior de Investigaciones Científicas posted this:
New treatment for epidermolysis bullosa and fibrosisCSIC, Carlos III University of Madrid and CIEMAT have repositioned drugs that stimulate endogline expression and modulate the TGF-β route for a new clinical use in the treatment of fibrosis, such as epidermolysis bullosa (EB). EB includes a heterogeneous group of rare hereditary diseases of the skin in which in its infantile incidence the patients are known as "butterfly children". It is a new therapy for a rare pathology, with potential in a wide spectrum of fibrosis, which would improve the possibilities of treatment of patients, improving their quality of life. Industrial partners from the pharmaceutical industry are being sought for its development in a wide variety of fibrotic pathologies through a patent licence agreement. An offer for Patent LicensingCovid-19 Innovation Challenges by Innoget posted this:
New use for an existing drug as antiviral agent against SARS-CoV-2 to prevent or/and treat COVID-19CSIC has discovered a new use for an existing drug on the market as antiviral agent. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Marta García Del BarrioConsejo Superior de Investigaciones Cientificas (CSIC)Marta García Del BarrioCommercialization Specialist at Consejo Superior de Investigaciones Cientificas (CSIC)
View ProfileMarta García Del Barrio posted this:
New use for an existing drug as antiviral agent against SARS-CoV-2 to prevent or/and treat COVID-19CSIC has discovered a new use for an existing drug on the market as antiviral agent. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Commercialization Specialist at Consejo Superior de Investigaciones Cientificas (CSIC)CSIC - Consejo Superior de Investigaciones Científicas posted this:
New use of cabergoline in breast cancer chemopreventionNew use of cabergoline in breast cancer chemoprevention A CSIC research group have found that Cabergoline exerts an increased latency and decreased breast cancer incidence in a mouse model deficient in Brca1/P53. An only single dose is needed to potentiate post-lactational gland involution and a decreasing of epithelial proliferation, providing less tumor susceptibility in mice. Results suggest Cabergoline could be a strong and safe protective drug for breast cancer prevention. It could be administered after breastfeeding to enhance the protective effect of pregnancy against breast cancer or later, to reduce the risk of post-pregnancy breast cancer in women over 30-35 years old. Pharmaceutical company is sough for further licensing. An offer for Patent LicensingCSIC - Consejo Superior de Investigaciones Científicas posted this:
New use of pasireotide-LAR in breast cancer chemopreventionNew use of pasireotide-LAR in breast cancer chemoprevention A group of CSIC researchers has demonstrated that treatment with Pasireotide-LAR once a month in mice models that develop breast cancer increases latency and decreases the incidence of breast cancer. Reduction of the ductal epithelial area was observed. Results suggest that Pasireotide-LAR could be a valuable drug for breast cancer chemoprevention and potentiate pregnancy's protective effect against breast cancer. Pharmaceutical company is sough for further development and licensing of use. An offer for Patent LicensingBeata Strach posted this:
New UV-blocker for sunscreen with high bactericidal activityThe offered material is based on ZnO nanoparticles, modified with biocompatible polymer – chitosan. The material is characterized by high absorption properties of the sun’s ultraviolet (UV) radiation. Also, high antibacterial activity against resistant bacterial strains and the absence of cytotoxic activity against human skin cells of the material were confirmed. Application: cosmetics, sunscreen, skincare, medical applications
Technology Transfer Officer at Jagiellonian UniversityCSIC - Consejo Superior de Investigaciones Científicas posted this:
New vaccine candidate against SARS-CoV-2 based on MVA vectorNew vaccine candidate against SARS-CoV-2 based on MVA vector. CSIC has developed a vaccine candidate based on a modified Vaccinia virus Ankara (MVA) vector, that contains a codon-optimized gene sequence encoding the Spike protein of SARS-CoV-2 coronavirus. This vaccine prototype can elicit a strong immune response in a mammal against COVID-19, according to their in vivo murine and hamster model assays. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent LicensingCSIC - Consejo Superior de Investigaciones Científicas posted this:
New vacine against MERS-CoV based on RNA repliconsCSIC has developed, using genetic engineering techniques, RNA replicons from the virus causing Middle East Respiratory Syndrome (MERS-CoV), encapsulated in Virus-Like Particles (VLPs), which can be used as a vaccine to generate immunity against infections by this coronavirus, according to their in vivo assays. Industrial partners are being sought to collaborate through a patent licence agreement. An offer for Patent LicensingCracow University of Technology posted this:
New way of detection Cryptosporidium and Giardia protozoa.Advantages of the technology: - Our method is sensitive, reproducible, species-specific and inexpensive way to detect Cryptosporidium sp. oocysts ad Giardia intestinalis cysts in various environmental samples. - There is not necessary to use highly specialized and expensive equipment. All the materials for realizing the invention (chemical reagents and equipment etc.) are commercially available. - It is not requirement the use of toxic flammable solvents to ensure the safety of personnel conducting the test. - The use of appropriate materials, allowed to simplify and shorten the work, to improve the reproducibility of detection and reduce the cost of detection procedure. - To achieve sensitive detection method allows subjecting the examination of much smaller volumes of liquid samples in comparison with that provided by the USEPA protocols (United States Environmental Protection Agency).SG PLAST posted this:
New way to treat plastic waste able to create new products for constructionTechnology able to mix a different kind of plastics types to produce a kind of plastic alloy with remarkable characteristics Our technology can create a material able to do bricks, tiles, etc That what we have now Potentially we can do almost all kind of products for the construction industry but we don t have the infrastructure neededUniversity of Vigo posted this:
New wheel slip reset controller for brake systemsThe main motivation for using reset control is the overcoming of fundamental limitations or trade-offs of conventional controllers: with the conventional controllers if we want a fast braking response, the system is fragile and sensitive to uncertainties; and if we want a robust system, this requires slower braking actions. Reset control is a novel technique that achieves more robust and fester braking responses in a way that no other conventional controller is able to produce.Georgetown University posted this:
Next-Generation Anti-Fungal Agents Targeting Candida Infections- Novel anti-fungal agents effective against drug-resistant Candida strains. - Reduced toxicity compared to traditional treatments like amphotericin B. - Suitable for high-risk groups, including HIV and cancer patients.Larisa Sheloukhova posted this:
Next-Generation Lignocellulosic MaterialsSDG implementation dictates the utilization of renewable natural resources. Woody biomass is a useful renewable organic resource. Plant cell wall is mostly made of polysaccarides, cellulose and hemicellulose, and lignin, which are linked together in a highly complex structure and comprise the bulk of trees’ biomass. Despite high potential of lignin, it is mostly discarded or burnt as a byproduct in the pulp and paper industry. Therefore, among the structural biomass compounds only the polysaccharides are used for various applications. The present invention is a novel method of biopolymer isolation including high quality lignin.
Global Tech Commercialization at Kyoto UniversityUNIVERSIDAD DE BURGOS posted this:
Nitrate ions removal from waterThe invention describes a method for synthesizing a bifunctional copolymer designed for the detection and removal of specific anions, such as nitrates, in drinking water. This material can be easily regenerated, allowing for repeated use over time and resulting in cost savings. Additionally, the copolymer synthesis does not require polymers or organic solvents, making the process more eco-friendly and efficient. Its effectiveness in purification process is visible to the user through a visual signal, such as a color change, which facilitates monitoring of the filtering material, ensuring timely maintenance or replacement.SUSANA CÁMARA DECIMAVILLA posted this:
Nitrate ions removal from waterThe invention describes a method for synthesizing a bifunctional copolymer designed for the detection and removal of specific anions, such as nitrates, in drinking water. This material can be easily regenerated, allowing for repeated use over time and resulting in cost savings. Additionally, the copolymer synthesis does not require polymers or organic solvents, making the process more eco-friendly and efficient. Its effectiveness in purification process is visible to the user through a visual signal, such as a color change, which facilitates monitoring of the filtering material, ensuring timely maintenance or replacement.
CEO at UNIVERSIDAD DE BURGOSRobert Estey posted this:
Nitric Oxide Chewing Gum Delivering in the Oral CavityThe Nitric Oxide (NO) gum is a simple solution for several complex medical issues facing consumers. The gum delivers nitric oxide into the oral cavity that favorably balances the oral microbiome and also delivers NO systemically to the body.
CEO at Per Os BiosciencesUniversitat de València posted this:
Nitrogen removal control system based on low-cost sensorsThis control system allows optimization of the activated sludge process since maintains effluent nitrogen concentration under limit values with minimum energy consumption. The most remarkable advantages provided by this technology are: Cost reduction of initial investment and maintenance Easier operation than nutrient analysers Lower time response Lower aireation energy consumption Lower pumping energy consumptionSimona Rataj posted this:
Nitroxoline for prevention and treatment of coronavirus diseaseUniversity of Ljubljana has repurposed Nitroxolin for the prevention and treatment of diseases caused by coronaviruses, in particular SARS-CoV-2. A significant advantage of nitroxoline over other candidate drugs for the treatment of covid-19 (repurposing drugs – amantadine, teicoplanin) is that the mechanism of action on the target has been extensively investigated. Our process can additionally generate a variety of compounds with improved antiviral activity.
Alliance Manager at University of Ljubljana
Behrouz Rahimi (NU)Nu innovations IncBehrouz Rahimi (NU)Inventor-problem solver-new product-solution-economic developer at Nu innovations Inc
View ProfileBehrouz Rahimi (NU) posted this:
NO BEAR ALLOWED.This devise prevent to entry of bears in rural area.This devise prevent to entry of bears in rural area. The “No Bears Allowed” prevents bears or other dangerous wild animals from entering one’s home or business. The product is especially ideal for those that live in rural areas where wild animals are nearby. It also helps people to protect their pets when playing or using the bathroom outside. This invention can also be used as a method of security from unwanted intruders. By using a specific range of ultrasonic waves, this device could directly affect the nerve structure of the bear to keep them away from the home without damaging humans or domestic animals. The inventor was inspired to create the idea because of personal experience. “I wanted to design something that would prevent wild animals from entering someone’s home,” said Rahimi. “I feel this product would help to keep people safe, especially those living in rural areas.”
Inventor-problem solver-new product-solution-economic developer at Nu innovations Inc






































